ÂÜÀòÂÒÂ×

Chris joined Oxford Nanopore Technologies in October 2020 from Sharp Corp, where he led the setup of Sharp Life Sciences.

Since joining Oxford Nanopore, Chris has guided the setup of subsidiary conpany structures. He will continue to lead and advise on key strategic projects and programmes for the Company, particularly looking to engage with markets beyond Life Science research tools, including potential clinical markets.